"We will continue to focus on a range of issues in relation to the PBS, of course, and important internal matters like governance, the Code of Conduct and listening to the membership - but our industry is also on the cusp of something quite extraordinary," says Vifor Pharma's James McDonnell. …
James McDonnell: Industry 'on the cusp of something quite extraordinary'
September 20, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Radiopharm says targeted therapy demonstrates potential for pancreatic cancer patients
November 18, 2024 - -
CLINUVEL announces plan to prioritises three strategic programs
November 18, 2024 - - Latest News -
The records and decisions in one year show that everything happens for a reason
November 18, 2024 - - Latest News -
Industry nerves after Trump appoints RFK Jr to lead US Health and Human Services
November 18, 2024 - - Latest News -
Australian company's candidate reduces aggregation of key ALS disease target
November 17, 2024 - - Australian Biotech -
A response based on short-term considerations only undermines long-term objectives
November 15, 2024 - - Latest News -
Amplia enters into preclinical collaboration with Korean drug screening company
November 14, 2024 - - Australian Biotech